Bioequivalence inspection program

Ended Awarded Last action

Contract number
HHSF22301004
Awardee
Awarding agency
Obligated
$633,222

Award facts

Contract value 100% obligated
$633,221.81 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
541611 Administrative Management and General Management Consulting Services
PSC
R499 Support- Professional: Other
Set-aside
No set-aside
Competition
Full and Open Competition · 0 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20036, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 1 · (other) TAS 75 0600 TAS cap cder-10-OC-620 bioequivalence inspection program BPI (task 3 of agency-wide BPI IO-223-SOL-00020) -$1,313
Original award $634,535

Quick answers

Who was awarded contract HHSF22301004?

HHSF22301004 was awarded to Mckinsey & Company, Inc. Washington D.c. by Food and Drug Administration (Department of Health and Human Services) on April 29, 2010.

How much is contract HHSF22301004 worth?

The government has obligated $633,222 on HHSF22301004.

Is contract HHSF22301004 an order under another contract?

Yes. HHSF22301004 is a BPA call under GS10F0118S-HHSF223201010014B, a blanket purchase agreement, on The Professional Services Schedule (PSS).

Was contract HHSF22301004 competed?

The extent of competition for HHSF22301004 was full and open competition. The government received 0 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award